Table 1.
Clinicopathological features of inflammatory breast cancer (IBC), non-IBC breast cancer patients and controls
| Patient characteristics | IBC | Non-IBC | Healthy | |||
|---|---|---|---|---|---|---|
| N = 20 | (% ) | N = 20 | (%) | N = 20 | (%) | |
| Age range | 34-70 | 29-78 | 21-80 | |||
| Mean age | 49.0 | 50.2 | 45.5 | |||
| Menopausal status | ||||||
| Pre-menopausal | 10 | 50% | 10 | 50% | 10 | 50% |
| Post-menopausal | 10 | 50% | 10 | 50% | 10 | 50% |
| Histological grade | ||||||
| I | 0 | 0% | 0 | 0% | ||
| II | 9 | 45% | 7 | 35% | ||
| III | 11 | 55% | 13 | 65% | ||
| Node status | ||||||
| N0 | 2 | 10% | 7 | 35% | ||
| N1 | 16 | 0% | 13 | 65% | ||
| N2 | 2 | 10% | 0 | 0% | ||
| N3 | 0 | 80% | 0 | 0% | ||
| Tumor | ||||||
| T1 | 0 | 0% | 0 | 0% | ||
| T2 | 0 | 0% | 6 | 30% | ||
| T3 | 0 | 0% | 13 | 65% | ||
| T4 | 20 | 100% | 1 | 5% | ||
| Metastasis | ||||||
| M0 | 14 | 70% | 4 | 20% | ||
| M1 | 0 | 0% | 2 | 10% | ||
| Unknown | 6 | 30% | 14 | 70% | ||
| ER status | ||||||
| Positive | 3 | 15% | 11 | 55% | ||
| Negative | 17 | 85% | 9 | 45% | ||
| PR status | ||||||
| Positive | 4 | 20% | 11 | 55% | ||
| Negative | 16 | 80% | 9 | 45% | ||
| HER2 status | ||||||
| Positive | 13 | 65% | 13 | 65% | ||
| Negative | 7 | 35% | 7 | 35% | ||